About Calcium News

Vitamin D is good for more than just bone strength (Valley Morning Star)

admin — Mon, 26 May 2008 04:07:48 +0000

We know that vitamin D helps the bones by preventing osteoporosis and fractures, but did you know that vitamin D also plays an important role in the prevention of many other diseases, including cancer, heart disease, autoimmune diseases like MS and Type 1 diabetes, arthritis, infections, chronic pain and muscle weakness?

Vitamin D is good for more than just bone strength (Valley Morning Star)

admin — Mon, 26 May 2008 04:07:48 +0000

Your Health: Vitamin D deficiency may cause pain and is underestimated (Tri-State Neighbor)

admin — Sun, 25 May 2008 17:47:29 +0000

Q:I’ve had extreme chronic pain in my lower back, pelvis, hips and legs for nearly four years. Lying flat was agony, so I had to sleep propped up on a love seat.

Wyeth Receives Approvable Letter From FDA For Bazedoxifene For The Treatment Of Postmenopausal Osteoporosis (Medical News Today)

admin — Sun, 25 May 2008 16:34:07 +0000

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) issued an approvable letter on May 21 for bazedoxifene, a selective estrogen receptor modulator, for the treatment of postmenopausal osteoporosis.

Approvable letter for Wyeth Pharmaceuticals osteoporosis drug (BizJournals)

admin — Sun, 25 May 2008 16:34:06 +0000

The Food and Drug Administration issued a third approvable letter for Wyeth Pharmaceuticals’ experimental drug bazedoxifene, which is being developed under the brand name Viviant to prevent postmenopausal osteoporosis. (WYE)

Wyeth osteoporosis drug gets 3d ‘approval’ letter (Philly.com)

admin — Sun, 25 May 2008 16:34:06 +0000

Wyeth Pharmaceuticals, Collegeville, announced today that it received its third “approvable” letter from the FDA for a drug being developed for the treatment of postmenopausal osteoporosis.

FDA wants more data on Wyeth osteoporosis drug (AP via Yahoo! Finance)

admin — Sun, 25 May 2008 16:34:06 +0000

Wyeth said Friday that U.S. regulators have again denied approval of the drug maker’s osteoporosis drug bazedoxifene requesting additional information on stroke and blood clot issues.

Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis (PR Newswire via Yahoo! Finance)

admin — Sun, 25 May 2008 16:34:06 +0000

Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration issued an approvable letter on May 21 for bazedoxifene, a selective estrogen receptor modulator, for the treatment of postmenopausal osteoporosis.

HIV Patients Suffer More From Osteoporosis (Science Daily)

admin — Sun, 25 May 2008 13:13:13 +0000

Following the introduction of HAART (Highly Active Antiretroviral Therapy), the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1) have increased in the resource-rich countries. However, with this improved prognosis an increase in long term negative disorders has been observed, namely osteoporosis (the gradual loss of bone mass). Osteoporosis is a …

Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World (FinanzNachrichten)

admin — Sun, 25 May 2008 10:56:59 +0000

Barcelona, Spain (ots/PRNewswire) - - In Europe, Less Screening and Treatment, and an Apparent Higher Prevalence of Hip Fracture Than in North America …